Home > Healthcare > Cell Separation Technologies Market
Cell Separation Technologies Market Size
Cell Separation Technologies Market size is projected to record substantial gains between 2024 and 2032, due to wide application scope of isolated cells in various life science research studies for enabling scientists to conduct molecular and epigenetic analysis.
Lately, biotech research and development activities are on the rise to create state-of-the-art medical technologies. For example, in September 2022, the U.S. government announced the funding of more than USD 2 billion to promote President Joe Biden’s National Biotechnology and Biomanufacturing Initiative. Such investments are likely to propel the development of cell separation technologies.
There has also been a notable increase in the incidence of different types of cancers across the globe. According to a journal of the American Cancer Society, 2,001,140 new cancer cases are estimated to occur in the U.S. in 2024. This increasing prevalence of cancer cases will amplify the industry growth.
Cell Separation Technologies Market Trends
The increasing adoption of microfluidic technologies for high-throughput cell sorting and isolation is driving the industry expansion. Label-free cell separation methods are being extensively used to minimize cell manipulation and preserve the cell viability. Rising advancements in magnetic cell separation techniques are enabling precise and efficient isolation of target cells. The integration of AI and machine learning algorithms for enhancing the automation and accuracy of cell separation processes.
Cell Separation Technologies Market Analysis
Based on technology, the industry value from the fluorescence-activated cell sorting (FACS) segment is estimated to rise at commendable CAGR from 2024 to 2032, owing to their high accuracy and multiparameter analysis in allowing effective separation of uncommon cell types. Significant advances in laser and detector technologies are increasing the sensitivity and resolution of FACS systems while boosting the cell sorting accuracy. The growing need for cell-based therapeutics and personalized medicine will boost the adoption of FACS for cell characterization and purification. Continuous innovation in FACS platforms and reagent development to cater to a wide range of research and clinical applications.
Cell separation technologies market from the stem cell research application segment is projected to rise at significant CAGR through 2032, on account of the rising focus on regenerative medicine and stem cell therapies. Advancements in cell separation technologies are offering purification and enrichment of specific stem cell populations for research and clinical applications. The growing prevalence of chronic diseases and aging population is also underscoring the need for innovative stem cell-based therapies, further fostering investments in cell separation technologies.
Europe cell separation technologies market size is expected to grow at a noteworthy rate between 2024 and 2032, owing to increased spending in biomedical research and development. The rising frequency of chronic illnesses and aging population is highlighting the need of customized medicine and cell-based therapeutics.
According to a WHO report, the population of individuals aged over 65 years will surpass those under the age of 15 in the WHO European Region. The higher prevalence of chronic disorders in the geriatric population is increasing the scope for cell separations technologies. There have been growing collaborations between academic institutions and biotechnology firms for promoting innovations. Surging government efforts and financing for life sciences research will also add to the regional industry gains.
Cell Separation Technologies Market Share
Some of the major cell separation technologies companies are:
- GE Healthcare
- Thermo Fisher Scientific
- EMD Millipore
- ZEISS
- PerkinElmer
- Bio-Rad Laboratories
- Akadeum Life Sciences
- STEMCELL Technologies
- Miltenyi Biotec
Leading companies in the cell separation technologies industry are undertaking mergers, acquisitions, partnerships, technology advancements and increased investments in R&D to broaden their product portfolios and establish a robust industry presence.
Cell Separation Technologies Industry News:
- In October 2022, Thermo Fisher Scientific Inc. introduced the Gibco™ CTS™ DynaCellect™ Magnetic Separation System (DynaCellect) to facilitate the transition of cell therapy developers from process and clinical development to commercial manufacturing.